Clinical Trials
3 trialsNCT05751733 2023-03-02
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Xiangya Hospital of Central South University
Phase NA Recruiting
NCT04690231 2022-03-15
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
Peking University People's Hospital
Phase NA Completed
NCT04260113 2021-01-05
AIAC
Peking University People's Hospital
Phase NA Completed